BMI
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 3.36 · operating margin 20%
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 751 titres (~101572 USD)
- Insiders
- Callahan Edward F.
- Total bought
-
$101,572
Avg buy (VWAP, 90d window) $135.25 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-07-30
- Last synced
-
2026-08-04 10:23:03
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-07-30 | Callahan Edward F. | Buy | 751 | $135.25 | $101,572 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-08-03
BMI exhibits genuinely strong financial fundamentals — zero debt, ~20% ROE, robust cash generation — earning a high liquidity score of 90, but the event-driven landscape is decisively negative with a catalyst score of…
The first sentence of the analysis written for BMI on 2026-08-03 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 41.7% | 39.8% | 39.3% | 38.9% | 40.7% | |
| Ebit Margin | 20.6% | 19.1% | 16.8% | 15.5% | 15.6% | |
| Ebitda Margin | 24.4% | 23.0% | 20.8% | 20.1% | 21.1% | |
| Operating Profit Margin | 20.0% | 19.1% | 16.8% | 15.4% | 15.6% | |
| Pretax Profit Margin | 20.6% | 20.1% | 17.3% | 15.5% | 15.6% | |
| Continuous Operations Profit Margin | 15.5% | 15.1% | 13.2% | 11.8% | 12.1% | |
| Net Profit Margin | 15.5% | 15.1% | 13.2% | 11.8% | 12.1% | |
| Bottom Line Profit Margin | 15.5% | 15.1% | 13.2% | 11.8% | 12.1% | |
| Current Ratio | 3.364 | 4.569 | 3.351 | 3.153 | 3.182 | |
| Quick Ratio | 2.356 | 3.356 | 2.186 | 2.067 | 1.969 | |
| Solvency Ratio | 0.677 | 0.748 | 0.602 | 0.577 | 0.695 | |
| Cash Ratio | 1.500 | 2.498 | 1.453 | 1.251 | 1.061 | |
| Price To Earnings Ratio | 36.185 | 49.793 | 48.851 | 47.820 | 50.986 | |
| Price To Earnings Growth Ratio | 2.753 | 1.430 | 1.266 | 5.260 | 2.222 | |
| Forward Price To Earnings Growth Ratio | 2.753 | 1.430 | 1.266 | 5.260 | 2.222 | |
| Price To Earnings Diluted Ratio | 36.411 | 50.147 | 49.162 | 48.243 | 51.231 | |
| Price To Earnings Diluted Growth Ratio | 2.750 | 1.445 | 1.263 | 5.575 | 2.220 | |
| Price To Book Ratio | 7.188 | 10.272 | 8.753 | 7.200 | 7.705 | |
| Price To Sales Ratio | 5.594 | 7.534 | 6.425 | 5.633 | 6.147 | |
| Price To Free Cash Flow Ratio | 30.219 | 43.785 | 46.075 | 41.610 | 38.453 | |
| Price To Operating Cash Flow Ratio | 27.912 | 40.165 | 41.053 | 38.637 | 35.488 | |
| Debt To Assets Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Debt To Equity Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.365 | 1.347 | 1.388 | 1.363 | 1.317 | |
| Working Capital Turnover Ratio | 2.356 | 2.258 | 2.569 | 2.714 | 3.017 | |
| Operating Cash Flow Ratio | 1.219 | 1.312 | 0.835 | 0.747 | 1.065 | |
| Operating Cash Flow Sales Ratio | 0.200 | 0.188 | 0.157 | 0.146 | 0.173 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.924 | 0.917 | 0.891 | 0.929 | 0.923 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditure Coverage Ratio | 13.097 | 12.095 | 9.174 | 13.996 | 12.972 | |
| Dividend Paid And Capex Coverage Ratio | 3.192 | 3.186 | 2.682 | 2.679 | 3.028 | |
| Dividend Payout Ratio | 0.307 | 0.287 | 0.314 | 0.374 | 0.364 | |
| Enterprise Value Multiple | 21.956 | 31.200 | 29.644 | 26.873 | 28.351 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 41.7% | ▲1.8% | ▲1.6% |
| Ebit Margin | 20.6% | ▲1.5% | ▲3.1% |
| Ebitda Margin | 24.3% | ▲1.4% | ▲2.5% |
| Operating Profit Margin | 20.0% | ▲0.9% | ▲2.6% |
| Pretax Profit Margin | 20.6% | ▲0.4% | ▲2.8% |
| Continuous Operations Profit Margin | 15.4% | ▲0.3% | ▲1.9% |
| Net Profit Margin | 15.4% | ▲0.3% | ▲1.9% |
| Bottom Line Profit Margin | 15.4% | ▲0.3% | ▲1.9% |
| Current Ratio | 3.365 | ▼-1.205 | ▼-0.160 |
| Quick Ratio | 2.356 | ▼-1.000 | ▼-0.031 |
| Solvency Ratio | 0.677 | ▼-0.071 | ▲0.017 |
| Cash Ratio | 1.500 | ▼-0.999 | ▼-0.053 |
| Price To Earnings Ratio | 36.185 | ▼-13.609 | ▼-10.542 |
| Price To Earnings Growth Ratio | 2.753 | ▲1.322 | ▲0.166 |
| Forward Price To Earnings Growth Ratio | 2.753 | ▲1.322 | ▲0.166 |
| Price To Earnings Diluted Ratio | 36.411 | ▼-13.735 | ▼-10.628 |
| Price To Earnings Diluted Growth Ratio | 2.750 | ▲1.306 | ▲0.100 |
| Price To Book Ratio | 7.188 | ▼-3.083 | ▼-1.035 |
| Price To Sales Ratio | 5.593 | ▼-1.940 | ▼-0.673 |
| Price To Free Cash Flow Ratio | 30.219 | ▼-13.566 | ▼-9.809 |
| Price To Operating Cash Flow Ratio | 27.912 | ▼-12.253 | ▼-8.739 |
| Debt To Assets Ratio | 0.000 | 0.000 | 0.000 |
| Debt To Equity Ratio | 0.000 | 0.000 | 0.000 |
| Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.365 | ▲0.018 | ▲0.009 |
| Working Capital Turnover Ratio | 2.356 | ▲0.098 | ▼-0.227 |
| Operating Cash Flow Ratio | 1.219 | ▼-0.093 | ▲0.183 |
| Operating Cash Flow Sales Ratio | 0.200 | ▲0.013 | ▲0.028 |
| Free Cash Flow Operating Cash Flow Ratio | 0.924 | ▲0.006 | ▲0.007 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Capital Expenditure Coverage Ratio | 13.097 | ▲1.002 | ▲0.830 |
| Dividend Paid And Capex Coverage Ratio | 3.192 | ▲0.006 | ▲0.238 |
| Dividend Payout Ratio | 0.307 | ▲0.020 | ▼-0.022 |
| Enterprise Value Multiple | 21.956 | ▼-9.244 | ▼-5.649 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $5.13B | $6.23B | $4.52B | $3.19B | $3.11B | |
| Enterprise value | $4.90B | $5.93B | $4.33B | $3.05B | $3.02B | |
| EV / Sales | 5.35x | 7.18x | 6.15x | 5.39x | 5.97x | |
| EV / Op. cash flow | 26.68x | 38.26x | 39.31x | 36.96x | 34.49x | |
| EV / Free cash flow | 28.89x | 41.71x | 44.12x | 39.81x | 37.37x | |
| EV / EBITDA | 21.96x | 31.20x | 29.64x | 26.87x | 28.35x | |
| Net debt / EBITDA | -1.01x | -1.55x | -1.31x | -1.22x | -0.82x | |
| Current ratio | 3.36x | 4.57x | 3.35x | 3.15x | 3.18x | |
| Income quality | 1.30x | 1.24x | 1.19x | 1.24x | 1.44x | |
| Graham number | $51 | $44 | $35 | $28 | $25 | |
| Graham net-net | $4 | $7 | $4 | $3 | $2 | |
| Tax burden | 75.1% | 75.0% | 75.9% | 75.8% | 77.4% | |
| Interest burden | 100.0% | 105.4% | 103.4% | 100.0% | 100.0% | |
| Working capital | $356.4M | $421.9M | $310.2M | $237.5M | $179.2M | |
| Invested capital | $793.8M | $656.8M | $554.7M | $465.9M | $431.4M | |
| Return on assets | 14.5% | 15.3% | 12.9% | 11.0% | 11.5% | |
| Operating ROA | 20.5% | 20.6% | 17.9% | 15.4% | 15.7% | |
| Return on tangible assets | 23.0% | 19.1% | 16.9% | 14.8% | 17.1% | |
| Return on equity | 19.9% | 20.6% | 17.9% | 15.0% | 15.1% | |
| Return on invested capital | 16.7% | 17.0% | 15.3% | 13.4% | 13.6% | |
| Return on capital employed | 22.3% | 22.6% | 20.2% | 17.7% | 17.5% | |
| Earnings yield | 2.8% | 2.0% | 2.0% | 2.1% | 2.0% | |
| Free cash flow yield | 3.3% | 2.3% | 2.2% | 2.4% | 2.6% | |
| Capex / Op. cash flow | 7.6% | 8.3% | 10.9% | 7.1% | 7.7% | |
| Capex / Depreciation | 40.6% | 39.8% | 42.7% | 22.4% | 24.2% | |
| Capex / Sales | 1.5% | 1.6% | 1.7% | 1.0% | 1.3% | |
| SG&A / Sales | 0.0% | 20.7% | 19.8% | 23.5% | 25.1% | |
| R&D / Sales | 0.0% | 2.3% | 2.7% | 2.8% | 2.9% | |
| Stock comp / Sales | 1.0% | 0.7% | 0.7% | 0.6% | 0.5% | |
| Intangibles / Total assets | 36.7% | 19.7% | 23.8% | 25.7% | 32.8% | |
| Days sales outstanding | 45d | 37d | 43d | 49d | 48d | |
| Days payables outstanding | 49d | 41d | 70d | 75d | 51d | |
| Operating cycle | 148d | 142d | 175d | 176d | 169d | |
| Cash conversion cycle | 99d | 102d | 105d | 101d | 118d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-17.7%EV / Sales ▼-25.5%EV / EBITDA ▼-29.6%EV / Op. cash flow ▼-11.579Earnings yield ▲+0.008Graham number ▲+6.814
Profitability
Return on equity ▼-0.008Return on assets ▼-0.008Return on invested capital ▼-0.002Return on capital employed ▼-0.003Operating ROA ▼-0.001Income quality ▲+0.056Tax burden +0.000
Efficiency
Days sales outstanding ▲+7.501Days payables outstanding ▲+8.517Operating cycle ▲+5.996Cash conversion cycle ▼-2.521Capex / Sales -0.000R&D / Sales ▼-0.023
Balance-sheet strength
Current ratio ▼-1.205Net debt / EBITDA ▲+0.541Working capital ▼-65550000.000Invested capital ▲+136961000.000Intangibles / Total assets ▲+0.171
Change over 5 years
Valuation
Market cap ▲+65.1%EV / Sales ▼-10.5%EV / EBITDA ▼-22.6%EV / Op. cash flow ▼-7.811Earnings yield ▲+0.008Graham number ▲+25.788
Profitability
Return on equity ▲+0.048Return on assets ▲+0.031Return on invested capital ▲+0.031Return on capital employed ▲+0.047Operating ROA ▲+0.048Income quality ▼-0.140Tax burden ▼-0.024
Efficiency
Days sales outstanding ▼-2.849Days payables outstanding ▼-1.614Operating cycle ▼-20.423Cash conversion cycle ▼-18.809Capex / Sales ▲+0.002R&D / Sales ▼-0.029
Balance-sheet strength
Current ratio ▲+0.183Net debt / EBITDA ▼-0.194Working capital ▲+177147000.000Invested capital ▲+362415000.000Intangibles / Total assets ▲+0.040
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-08-03 CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Badger Meter (BMI) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 NEW YORK--(BUSINESS WIRE)---- $BMI #BMI--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Badger Meter, Inc. (“Badger Meter” or the “Company”) (NYSE: BMI) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm.
- 2026-08-03 Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New class action for Badger Meter (BMI) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/3/2026
- 2026-08-03 Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - August 3, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
- 2026-08-03 BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstBadger Meter, Inc. ("Badger" or "the Company") (NYSE: BMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of BMI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
- 2026-08-03 Badger Meter, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BMI LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Badger Meter, Inc. ("Badger" or "the Company") (NYSE: BMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of BMI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
- 2026-08-02 BMI SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Badger Meter (BMI) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Badger Meter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Badger Meter between April 18, 2024 and April 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 2, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Badger Meter, Inc. ("Badger Meter" or the "Company") (NYSE: BMI) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 2026-08-02 Badger Meter Deadline Tomorrow: BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit Badger Meter Deadline Tomorrow: BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit PR Newswire
- 2026-08-02 Badger Meter Deadline Tomorrow: BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit NEW YORK, Aug. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline. So what: If you purchased Badger Meter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 2026-08-01 BADGER METER DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Badger Meter, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - BMI New York, New York--(Newsfile Corp. - August 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Badger Meter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 2026-08-01 BADGER METER DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Badger Meter, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - BMI NEW YORK, Aug. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Badger Meter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.